Live feed
Filing
SC 13G
SC 13G0001839882-21-002170·Atlas Venture Fund XI, L.P.
Schedule 13G ownership disclosure
Dyne Therapeutics Inc
Security class unavailable · CUSIP: 26818M108
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 81,401,301
- Percent of class
- 17.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-21-002170
- Form type
- SC 13G
- Filer
- Atlas Venture Fund XI, L.P.
- CIK
- CIK 1708269
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership